Explore All 3112 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | September 18, 2019 |
| Target | Medimetrics |
| Sector | Life Science |
| Buyer(s) | Biora Therapeutics |
| Sellers(s) | Zukunftsfonds Heilbronn |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2010 |
| Sector | Life Science |
| Employees | 58 |
| Revenue | 1M USD (2021) |
Biora Therapeutics is a clinical-stage biotechnology company developing oral therapeutic-delivery platforms for needle-free systemic delivery of large molecules and targeted therapy delivery in the gastrointestinal tract. Biora Therapeutics was founded in 2010 and is based in San Diego, California.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science | 2 of 2 |
| Type: Add-on Acquisition | 2 of 2 |
| Country: Germany | 1 of 1 |
| Year: 2019 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-04-29 |
Carmenta Bioscience
Palo Alto, California, United States Carmenta Bioscience, Inc. develops diagnostic test preeclampsia diagnostic development. |
Buy | - |
| Category | Family Office |
|---|---|
| Founded | 2005 |
| PE ASSETS | 200M USD |
| Size | Small |
| Type | Sector Agnostic |
Zukunftsfonds Heilbronn is a family backed growth investor focused on emerging companies in the Heilbronn area of Germany. Zukunftsfonds Heilbronn was established in 2005 and is headquartered in Heilbronn, Germany.
| Deal Context for Seller | # |
|---|---|
| Overall | 5 of 6 |
| Sector: Life Science | 1 of 2 |
| Type: Add-on Acquisition | 3 of 3 |
| Country: Germany | 5 of 6 |
| Year: 2019 | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-10 |
Medineering
Munich, Germany Medineering develops, manufactures and markets an application-specific and convenient robotic portfolio. The portfolio consists of the Medineering Positioning Arm and compact application-specific robots assisting surgeons in complex anatomical regions. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-12 |
PL BioScience
Aachen, Germany PL BioScience is an expert in cell culture supplements derived from human Platelets. PL BioScience's mission is to enhance the advances in cellular research and therapy with forward-looking cell growth promoters. PL BioScience was founded in 2015 and is based in Aachen, Germany. |
Buy | - |
